Sionna Pharma (SION): Qarzning balans kapitallashuviga nisbati

Sionna Corp (SION) - korporativ logo

GURU.Markets platformasidagi Sionna Therapeutics Inc (SION) narxlar grafigi medtech sohasiga bo'lgan barqaror talab tufayli makroiqtisodiy zarbalardan himoyalangan aktivni namoyish etadi, bunda ko'rsatkich 0.03 darajasida turibdi. Biznes kistik fibrozisni davolashga ixtisoslashgan bo'lib, tartibga soluvchi to'siqlar va patent raqobati bilan yuzlashmoqda. Xarajatlarni optimallashtirish uchun Sionna Therapeutics Inc (SION) dori ishlab chiqarish va sinovlarini tashqi pudratchilarga topshiradi va faqat ilm-fanga e'tibor qaratadi.

Sionna Therapeutics Inc - SION Sof aktivlarga qarzlar (davr: 08.02.2025 - 29.10.2026)

Sionna Therapeutics, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (SION)

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya narxi Sionna Therapeutics Inc|SION - Tahlilchilar konsensus prognozi
- birja kapitallashuvi ma'lumotlari:
Bozor qiymati Sionna Corp|SION - Kompaniyani sotib olish narxi
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Sionna Therapeutics|SION - Biznesning balans bahosi|Bozor qiymatining balans qiymatiga nisbati sionnatx.com|SION - Kompaniya aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Sionna Therapeutics Inc|SION - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning o'z kapitaliga nisbati Sionna Pharma|SION - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Sionna Corp|SION - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Sionna Therapeutics|Tezkor likvidlik ko‘rsatkichi sionnatx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
SION - Soliqlar to‘langandan keyingi foyda
Kompaniyaning fundamental baholanishi:Sionna Therapeutics Inc SION
Sionna Pharma original mahsuloti

Ushbu ko'rsatkich kredit risklarini jami qarz mablag'larining kapitalning balans qiymatiga nisbati orqali baholaydi, bunda pastroq koeffitsient bozor shoklari paytida yo'qotishlar ehtimolini minimallashtiradi. Balansdagi moliyaviy leverajning dinamik tendentsiyasini tahlil qilish orqali investor qarz yuklamasi va daromadlilik o'rtasidagi muvozanatni kuzatishi mumkin, bu esa Sionna Therapeutics Inc (SION) uchun qimmat RNA tadqiqotlari va kistik fibrozga qarshi dori vositalarini birgalikda ishlab chiqishni moliyalashtirishda juda muhimdir.

Sionna Therapeutics Inc raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|IONS - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Repligen Corp RGEN|RNA: Balans kapitallashuviga qarzlar|CRSP - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati GeneDx Holdings Corp.|Balans qiymatiga qarzlar ultragenyx.com RARE|Qarzning balans kapitallashuviga nisbati Beam Therapeutics (BEAM)|Sarepta Therapeutics - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Twist Bio TWST|TXG: Qarzning balans qiymatiga nisbati|Intellia Therapeutics - Balans kapitallashuviga qarzlar|STOK - Balans kapitallashuviga qarzlar|BLFS (BioLife Solutions) - Qarzning balans qiymatiga nisbati|Wave Life Sciences Ltd - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati MAZE|PRME (Prime Medicine Bio) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar TSHA|QURE (uniqure.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar MGTX (MeiraGTx)|REGENXBIO Inc (RGNX) - Balans qiymatiga qarzlar|SLDB - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati OCGN (Ocugen Pharma)|PACB: Balans kapitallashuviga qarzlar|benitec.com (BNTC) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Design Therapeutics, Inc.|Rocket Pharma - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar FDMT|LXEO - Balans qiymatiga qarzlar|Korro Bio - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar editasmedicine.com EDIT|SLN: Qarzning balans qiymatiga nisbati|ProQR Therapeutics N.V. - Qarzning balans kapitaliga nisbati|CDXS: Balans kapitallashuviga qarzlar|SGMO - Sof aktivlarga qarzlar|NAUT (Nautilus Biotechnology, Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati metagenomi.co (MGX)|Qarzning balans kapitallashuviga nisbati Precision BioSciences, Inc. (DTIL)|Sof aktivlarga qarzlar generationbio.com|Boundless Bio, Inc - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati XCUR|Celsion Corporation - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Phio Pharmaceuticals PHIO|mustangbio.com (MBIO) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati RNAZ|BNGO (Bionano Genomics Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Applied DNA Corp (APDN)|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. (BLUE)|Sof aktivlarga qarzlar immunoprecise.com|Balans kapitallashuviga qarzlar OMGA (Omega Therapeutics, Inc.)|Sof aktivlarga qarzlar Singular Genomics Systems, Inc. (OMIC)|RGLS - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Syros Pharmaceuticals, Inc|Telesis Bio, Inc. (TBIO) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati TCON|UBX (Unity Biotechnology, Inc.) - Balans kapitallashuviga qarzlar